Major political donors in the health care and pharmaceutical industries pumped more than $1.3 million into legislative campaigns in the 2022 election cycle, ahead of a 2023 legislative session likely to be rife with fierce debate over health care issues.
Nate Glubish, Alberta minister of technology and innovation, along with other government officials announced federal funding that will go toward increasing Alberta’s pharmaceutical capabilities. (David Bajer/CBC) The federal government has announced more …
TALK ABOUT THAT COMING UP. THIS MORNING. ONE WOMAN IS IN THE HOSPITAL AFTER BEING SHOT IN WINSTON-SALEM. POLICE SAY THEY WERE CALLED TO PEACE COURT JUST BEFORE 9:00 LAST NIGHT AND OFFICERS FOUND A 21 YEAR OLD WOMAN SHOT INSIDE AN APARTMENT BUILDING RIGHT …
The universal Pharmaceutical Robots market analysis report will surely lend a hand in growing sales and improve return on investment (ROI). The company profiles of all the top market players and brands with moves like product launches,
Atsushi Matsuzawa, Professor at the Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University The team’s findings were published in The Journal of Immunology on February 6, 2023. These TKIs are essential anticancer drugs.
The most recent research report by MarkNtel Advisors on the Pharmaceutical Blister Packaging Market includes an examination of numerous aspects that contribute to the market growth during the forecast period 2023-2028. The report provides space for …
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN – Research
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers. Eli Lilly announced this month it would cut the US price of its insulin by 70 percent and Novo Nordisk followed suit by saying it
The “2 Day Seminar Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries) – New Course!” training has been added to
“In the research perspective, we collaborated with the National Pharmaceutical Council to explore how payers are using value assessment information in their decision-making, and then we’ll have some information on how payers are using this in the real …